Refile: TABLE-Sawai Pharmaceutical -Q1 group results

SAWAI group

14/08/2017 07:12

(Adds company forecast. Accounting policy for forecast is IFRS) 
Aug 14 (Reuters)-  
Sawai Pharmaceutical Co Ltd  
CONSOLIDATED FINANCIAL HIGHLIGHTS 
(in billions of yen unless specified) 
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2017        Jun 30, 2016     Mar 31, 2018 
                     LATEST             YEAR-AGO          LATEST 
                     RESULTS             RESULTS         FORECAST 
  Sales               33.65               32.95 142.00 
                   (+2.1 pct)          (+12.1 pct) 
  Operating            5.38                5.89            24.20 
                   (-8.7 pct)          (-7.3 pct) 
  Recurring            6.11                5.91            23.80 
                   (+3.3 pct)          (-5.6 pct) 
  Net                  4.66                4.36            18.20 
                   (+6.9 pct)          (-14.4 pct) 
  EPS              126.31 yen          118.19 yen        493.65 yen 
  EPS Diluted      126.23 yen          118.13 yen 
  Ann Div                              130.00 yen       130.00 yen 
  -Q2 div                               65.00 yen        65.00 yen 
  -Q4 div                               65.00 yen        65.00 yen 
 
NOTE - Sawai Pharmaceutical Co Ltd. 
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4555.T ((Tokyo 
Headline News Desk +813 6441 1812))